Nanoliposomal Irinotecan in the Clinical Practice Guideline for Metastatic Pancreatic Cancer: Applicability to Clinical Situations Reply

被引:0
|
作者
Sohal, Davendra P. S. [1 ]
Mangu, Pamela B. [2 ]
Laheru, Daniel [3 ]
Khorana, Alok A. [1 ]
机构
[1] Cleveland Clin, Cleveland, OH 44106 USA
[2] Amer Soc Clin Oncol, Alexandria, VA USA
[3] Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA
关键词
D O I
10.1200/JCO.2016.70.7463
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:690 / +
页数:2
相关论文
共 50 条
  • [1] Nanoliposomal Irinotecan in the Clinical Practice Guideline for Metastatic Pancreatic Cancer: Applicability to Clinical Situations
    Wang-Gillam, Andrea
    Von Hoff, Daniel
    Siveke, Jens
    Hubner, Richard
    Belanger, Bruce
    Pipas, J. Marc
    Chen, Li-Tzong
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06) : 689 - +
  • [2] Nanoliposomal irinotecan in metastatic pancreatic cancer
    Milosevic, Ioan
    Drysdale, Henry
    Goldacre, Ben
    LANCET, 2016, 387 (10032): : 1997 - 1997
  • [3] Metastatic Pancreatic Cancer: ASCO Clinical Practice Guideline Update
    Sohal, Davendra P. S.
    Kennedy, Erin B.
    Khorana, Alok
    Copur, Mehmet S.
    Crane, Christopher H.
    Garrido-Laguna, Ignacio
    Krishnamurthi, Smitha
    Moravek, Cassadie
    O'Reilly, Eileen M.
    Philip, Philip A.
    Ramanathan, Ramesh K.
    Ruggiero, Joseph T.
    Shah, Manish A.
    Urba, Susan
    Uronis, Hope E.
    Lau, Michelle W.
    Laheru, Daniel
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (24) : 2545 - +
  • [4] Metastatic Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice Guideline
    Sohal, Davendra P. S.
    Mangu, Pamela B.
    Khorana, Alok A.
    Shah, Manish A.
    Philip, Philip A.
    O'Reilly, Eileen M.
    Uronis, Hope E.
    Ramanathan, Ramesh K.
    Crane, Christopher H.
    Engebretson, Anitra
    Ruggiero, Joseph T.
    Copur, Mehmet S.
    Lau, Michelle
    Urba, Susan
    Laheru, Daniel
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (23) : 2784 - +
  • [5] Metastatic Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice Guideline Summary
    Sohal, Davendra P. S.
    Mangu, Pamela B.
    Laheru, Daniel
    JOURNAL OF ONCOLOGY PRACTICE, 2017, 13 (04) : 261 - +
  • [6] Update on the role of nanoliposomal irinotecan in the treatment of metastatic pancreatic cancer
    Rahman, F. N. U. Asad ur
    Ali, Saeed
    Saif, Muhammad Wasif
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2017, 10 (07) : 563 - 572
  • [7] Nanomedicine developments in the treatment of metastatic pancreatic cancer: focus on nanoliposomal irinotecan
    Ko, Andrew H.
    INTERNATIONAL JOURNAL OF NANOMEDICINE, 2016, 11 : 1225 - 1235
  • [8] JPS clinical practice guideline for pancreatic cancer
    Yamaguchi, Koji
    Shiratori, Keiko
    Funakoshi, Akihiro
    Karasawa, Katsunori
    Ishikawa, Osamu
    Tanaka, Masao
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2007, 22 : A93 - A93
  • [9] Nanoliposomal irinotecan for treating pancreatic cancer
    Grapsa, Dimitra
    Syrigos, Konstantinos
    Saif, Muhammad Wasif
    EXPERT OPINION ON ORPHAN DRUGS, 2016, 4 (05): : 541 - 547
  • [10] Pancreatic Cancer Nanoliposomal Irinotecan as a new Treatment Option
    Franke, Katharina
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2016, 54 (07): : 616 - 618